Skip to content
Review

Engineering Cell Membrane-Coated Nanoparticles: A Route for Enhanced Therapeutic Efficacy.

Oct 2026 · ACS Applied Materials and Interfaces · Vol 18, pp. 56995-57014 · 0 citations · 179 references
Medicine

TL;DR

This work highlights membrane engineering-enabled biological regulation of nanomaterials, offering rational guidelines for the design and scalable fabrication of next-generation biomimetic nanotherapeutics.

Abstract

Cell membrane-coated nanoparticles (CMNPs) have emerged as versatile biomimetic nanoplatforms that inherit native membrane biofunctions, such as immune evasion, specific molecular recognition, and prolonged systemic circulation. Nevertheless, conventional CMNPs suffer from low surface ligand density and weak microenvironment responsiveness, leading to unsatisfactory functional homogeneity and restricted translational applicability. These limitations directly translate into key clinical challenges, including poor active targeting capability, rapid in vivo clearance, and insufficient tumor penetration. To tackle these material engineering limitations, engineered (ECMNPs) have been developed through modular membrane engineering to enable precise and programmable surface functionalization. This review systematically summarizes five mainstream membrane modification strategies for ECMNP construction, including stimuli-responsive functionalization, genetic engineering, covalent conjugation, noncovalent assembly, and membrane fusion. By integrating endogenous membrane bioactivity with artificially optimized nanostructures, ECMNPs exhibit tunable targeting capability, stimuli-triggered drug release, immunomodulatory effects, and enhanced transbarrier delivery for treating intractable diseases. We further discuss key translational bottlenecks regarding membrane sourcing, extraction procedures, structural stability, and biological safety. This work highlights membrane engineering-enabled biological regulation of nanomaterials, offering rational guidelines for the design and scalable fabrication of next-generation biomimetic nanotherapeutics.

View source

Similar papers

Review Open access Oct 2026

Cell Membrane-Coated Nanoparticles as Biomimetic Drug Delivery Systems: Design, Therapeutic Applications, and Translational Challenges

Biomimetic cell membrane-coated nanoparticles (CM-NPs) have emerged as a promising class of nanocarriers that integrate the tunable physicochemical properties of engineered nanoparticles with selected biological features of naturally derived cell membranes. By retaining membrane-associated proteins, lipids, glycans, an...

Shery Jacob, Namitha Raichel Varkey, Rekha Rao et al. · 0 citations
Review Open access Nov 2026

Biomimetic Cell Membrane-Engineered Covalent Organic Frameworks for Smart Drug Delivery: Design Principles, Engineering Strategies, and Translational Challenges

Covalent organic frameworks (COFs) have attracted growing interest as drug delivery platforms owing to their ordered porosity, tunable pore architecture, and versatile chemical functionality. Favorable physicochemical characteristics alone, however, do not guarantee effective performance in vivo, and biomimetic membran...

Hina Ali, Hayat Khan, Javed Muhammad et al. · 0 citations
Review Open access Oct 2026

Integrating nanomaterials with extracellular vesicles: engineering strategies and translational perspectives

Extracellular vesicles (EVs), particularly stem cell-derived exosomes, serve as vital natural nanocarriers in regenerative medicine, immune modulation, and targeted drug delivery due to their innate ability to transport bioactive cargo across complex biological barriers. Despite this potential, the therapeutic efficacy...

T. Le, L. Phan · 0 citations
Review Open access Sep 2026

Extracellular vesicles in targeted drug delivery: from biological functions to surface engineering

The application of engineered EVs in the treatment of several pathological conditions, including cardiovascular, neurological, autoimmune, and cancer diseases, are summarized, and the major challenges in clinical translation and future perspectives for EV-based targeted therapies are discussed.

Giulia Duca, Vincenza Tinnirello, N. Ganji et al. · 1 citation
Review Open access Sep 2026

Designing nature's nanocarriers: advances and challenges in functionalizing bacterial extracellular vesicles.

This review examines luminal targeting strategies (secretion pathway-mediated loading, lipoprotein anchoring, and membrane scaffold fusions), surface display platforms, and genetic yield-enhancement mechanisms to advance bEVs toward clinically viable, programmable delivery systems.

Varun Kumar, Hannah C. Zierden, Sara Molinari · 0 citations
Oct 2026

Exosome-Based Targeted Drug Delivery Systems: Current Advances and Challenges

Exosomes are naturally occurring nanovesicles (30–150nm) that serve as biological carriers for the targeted delivery of medicinal substances. Their membrane composition facilitates passage over physiological barriers, such as the blood-brain barrier, and offers good compatibility with bodily tissues. Using methods like...

Dhananjay A. Deore, S. Jadhav, S. Mahajan · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.